Overview
Gregory Kalemkerian is an Oncologist in Ann Arbor, Michigan. Dr. Kalemkerian is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is currently accepting new patients.
His clinical research consists of co-authoring 84 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 26 articles in the study of Small Cell Lung Cancer (SCLC).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Henry Ford Health System
Shirish Gadgeel is an Oncologist and a Hematologist Oncology provider in Detroit, Michigan. Dr. Gadgeel is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.
Barbara Ann Karmanos Cancer Institute
Hirva Mamdani is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Mamdani is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma. Dr. Mamdani is currently accepting new patients.
Regents Of The University Of Michigan
Bryan Schneider is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Schneider is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Kalemkerian isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Kalemkerian isElite. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Kalemkerian isElite. Learn about Small Cell Lung Cancer (SCLC).
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Kalemkerian isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Kalemkerian isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Kalemkerian isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Kalemkerian isDistinguished. Learn about Lung Adenocarcinoma.
- MesotheliomaDr. Kalemkerian isDistinguished. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Kalemkerian isDistinguished. Learn about Metastatic Pleural Tumor.
- Advanced
- Metastatic Brain TumorDr. Kalemkerian isAdvanced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Kalemkerian isAdvanced. Learn about Neuroendocrine Tumor.
- Thymic Epithelial TumorDr. Kalemkerian isAdvanced. Learn about Thymic Epithelial Tumor.
- Experienced
- AgranulocytosisDr. Kalemkerian isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Kalemkerian isExperienced. Learn about Anal Cancer.
- Brain TumorDr. Kalemkerian isExperienced. Learn about Brain Tumor.
- Cushing's syndrome due to Adrenal TumorDr. Kalemkerian isExperienced. Learn about Cushing's syndrome due to Adrenal Tumor.
- EmphysemaDr. Kalemkerian isExperienced. Learn about Emphysema.
- Lung NodulesDr. Kalemkerian isExperienced. Learn about Lung Nodules.